Skip to main content
NNVC logo

NanoViricides, Inc.

NNVCNYSEAMERICANHealthcareBiotechnology

$1.38Today:- (-)1Y −8.67%

As of Oct 16, 2026 close

Market cap
$27.66M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.85$2.23
Volume (live)
-
Avg. volume (3M)
531.83K

NanoViricides (NNVC) Cash Flow Statement

In fiscal 2026 (fiscal year ended Jun 30, 2026), NanoViricides used $7.70M of cash in operating activities and spent $84.32K on capital expenditures. That left free cash flow of −$7.78M.

NanoViricides Cash Flow Statement Analysis

Values in trillions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for NanoViricides, Inc. (NNVC) - Annual data in trillions USD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Operating Activities
Net Income-8.220.000.000.000.000.000.000.000.000.00
Depreciation & Amortization0.520.000.000.000.000.000.000.000.000.00
Deferred Income Tax0.000.000.000.000.000.000.000.000.000.00
Stock Based Compensation0.000.000.000.000.000.000.000.000.000.00
Change in Working Capital0.000.000.000.000.000.000.000.000.000.00
Change in Accounts Payable0.000.000.000.000.000.000.000.000.000.00
Change in Other Working Capital0.000.000.000.000.000.000.000.000.000.00
Other Operating Activities-0.040.000.000.000.000.000.000.000.000.00
Net Cash from Operating Activities0.000.000.000.000.000.000.000.000.000.00
Investing Activities
Capital Expenditures0.000.000.000.000.000.000.000.000.000.00
Net Cash from Investing Activities0.000.000.000.000.000.000.000.000.000.00
Financing Activities
Debt Repayment0.000.000.000.000.000.000.000.000.000.00
Common Stock Issued0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities9.020.000.000.000.000.000.000.000.000.00
Net Cash from Financing Activities0.000.000.000.000.000.000.000.000.000.00
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.000.000.000.000.00
Net Change in Cash0.000.000.000.000.000.000.000.000.000.00
Cash at Beginning of Period1.560.000.000.000.000.000.000.000.000.00
Cash at End of Period2.790.000.000.000.000.000.000.000.000.00
Free Cash Flow0.000.000.000.000.000.000.000.000.000.00
Supplemental Disclosures
Interest Paid-0.00-0.000.000.00----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About NanoViricides Cash Flow

What is NanoViricides's free cash flow?

NanoViricides had negative free cash flow of $7.78M in fiscal 2026 (fiscal year ended Jun 30, 2026), operating cash flow of −$7.70M minus $84.32K of capital expenditures.

How much does NanoViricides spend on capital expenditures?

NanoViricides spent $84.32K on capital expenditures in fiscal 2026, compared with $56.96K a year earlier.

Does NanoViricides pay dividends or buy back shares?

NanoViricides's cash flow statement for fiscal 2026 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition